| Entry |
|
|---|
| Name |
Vidarabine phosphate (USAN)
|
|---|
| Formula |
C10H14N5O7P
|
|---|
| Exact mass |
347.0631
|
|---|
| Mol weight |
347.2212
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
|
|---|
| Comment |
Arabinofuranosyl derivative
|
|---|
| Target |
DNA polymerase inhibitor [EC: 2.7.7.7] |
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB03 Vidarabine
D06299 Vidarabine phosphate (USAN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD06 Vidarabine
D06299 Vidarabine phosphate (USAN)
Antiinfectives [BR:br08307]
Antivirals
Anti-HSV agent
DNA polymerase inhibitor
Pyrimidine analogue
Vidarabine [ATC:J05AB03 S01AD06]
D06299 Vidarabine phosphate (USAN)
 |
|---|
| Other DBs |
CAS: 29984-33-6 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 23
1 N4y N 26.9105 -17.9268
2 C8y C 27.9563 -18.6937
3 C1y C 25.5859 -18.3451
4 C8x C 27.3288 -16.5324
5 C8y C 29.1415 -17.7874
6 N5x N 28.0957 -20.0881
7 O2x O 24.4704 -17.5085
8 C1y C 25.1676 -19.6000
9 N5x N 28.7929 -16.5324
10 C8y C 30.3964 -18.3451
11 C8x C 29.4204 -20.6458
12 C1y C 23.3549 -18.2754
13 C1y C 23.7732 -19.6000
14 N5x N 30.6056 -19.8092
15 N1a N 31.5119 -17.5085
16 C1b C 22.0303 -17.8571
17 O1a O 23.3549 -20.9247
18 O2b O 20.9845 -18.8331
19 P1b P 19.5902 -18.8331
20 O1c O 18.1958 -18.8331
21 O1c O 19.5902 -20.2275
22 O1c O 19.5902 -17.3691
23 O1a O 25.9968 -20.7511
BOND 25
1 1 2 1
2 3 1 1 #Up
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 6 11 2
11 7 12 1
12 8 13 1
13 10 14 2
14 10 15 1
15 12 16 1 #Up
16 13 17 1 #Down
17 16 18 1
18 18 19 1
19 19 20 1
20 19 21 1
21 19 22 2
22 5 9 1
23 11 14 1
24 12 13 1
25 8 23 1 #Up
|
|---|
